Purchase Order 75F40125P00201
- Not listed
- The Department of Health and Human Services Food and Drug Administration awarded a $248,024 firm fixed price purchase order to Schrodinger, LLC for a SMALL MOLECULE DRUG DISCOVERY SUITE LICENSE. As a division of Schrodinger, Inc., Schrodinger, LLC will provide its proprietary small molecule drug discovery software suite to support the FDA's drug review and research efforts. Performance will take place in Portland, Oregon over a five-year period concluding in July 2028. No subcontractors or set...
- This is a $485,702 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Schrodinger LLC, a subsidiary of Schrodinger, Inc. The contract is for Schrodinger's LiveDesign software and Comptox software, which support the FDA's drug review, research, and computational capabilities for drug discovery and development across various therapeutic areas. This award is not associated with a larger contract vehicle and does not have a set-aside designation. Schrodinger LLC...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a Firm Fixed Price definitive contract to Schrodinger LLC, a division of Schrodinger, Inc., for the renewal of the Schrodinger Suite chemical simulation software licenses, specifically the Small Molecule Drug Discovery Suite. The $141,000.00 contract supports the FDA's National Center for Toxicological Research (NCTR) Division of Bioinformatics and Biostatistics (DBB) ongoing computational chemistry...
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Schrodinger LLC, a division of Schrodinger, Inc. The contract is for a Schrodinger Suite software license with maintenance and support, with a ceiling value of $288,254. The contract has an ultimate completion date of June 27, 2028. Schrodinger LLC is a leading provider of advanced computational tools for drug discovery and materials science, primarily serving government agencies within the...
- This is a firm-fixed-price purchase order awarded by a civilian federal agency, the Northeast Area of an unspecified agency, to Schrodinger LLC, a division of Schrodinger, Inc. The $8,199 contract is for the provision of Schrodinger's specialized chemical simulation software, including the Small Molecule Drug Discovery Suite, Schrodinger Suite, LiveDesign, Comptox, and Materials Science Suite. These software products are used to support drug review, research efforts, and computational...
- This federal contract award was made by an unspecified U.S. government agency to Schrodinger, Inc., a for-profit organization that develops chemical simulation software for the pharmaceutical, biotechnology, and materials research industries. The $128,335.00 firm-fixed-price purchase order provides Schrodinger with 11-month floating software licenses for its MACROMODEL, GLIDE, and related software modules. The contract does not have a set-aside designation. Schrodinger is an experienced...
- This is a firm-fixed-price purchase order awarded by the Center for Information Technology (CIT), part of the Department of Health and Human Services (HHS), to Schrodinger LLC, a leading provider of molecular modeling and simulation software. The $149,600 contract is for the renewal of Schrodinger's molecular modeling software licenses, with a period of performance from July 1, 2016, to June 30, 2017. The contract does not have a set-aside designation, reflecting Schrodinger's specialized...
- This is a firm-fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), part of the U.S. Department of Health and Human Services, to Schrodinger LLC. The $200,325.00 contract provides for the renewal of Schrodinger's Small Molecule Drug Discovery Suite software licenses to support COVID-19 research efforts. Schrodinger LLC is a subsidiary of the parent company Schrodinger, Inc., which has received numerous federal contract and grant awards,...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $208,875.00 firm fixed-price purchase order for a Schrodinger software license to Schrodinger LLC, a division of Schrodinger, Inc. The contract is for the provision of Schrodinger's state-of-the-art chemical simulation software to support the CDC's drug review, research, and computational needs. Schrodinger LLC has received over 20 similar federal contracts from agencies including the Department of...
- This is a $99,570.76 firm-fixed-price purchase order awarded by the U.S. Air Force Research Laboratory (AFRL) to Schrodinger LLC, a subsidiary of Schrodinger, Inc. The contract is for the renewal of software licenses for Schrodinger's computational drug design and materials simulation software. This includes products such as the Small Molecule Drug Discovery Suite, Schrodinger Suite, LiveDesign, Comptox, and Materials Science Suite. The award supports AFRL's research and development efforts,...
The Food and Drug Administration has awarded a $108,875 firm-fixed-price purchase order to Schrodinger LLC for a Molecular Dynamics Modeling Simulation Platform Software License. The contract, awarded on September 2, 2025, with an ultimate completion date of September 2, 2026, will be performed in Portland, Oregon. No set-aside designation was utilized in this award, indicating the vendor was selected based on the merits of its specialized computational chemistry and molecular modeling capabilities. Schrodinger LLC, a leading provider of advanced computational chemistry and molecular modeling software, has established itself as a critical technology partner for federal research initiatives, particularly within the Department of Health and Human Services. The company's software tools support drug discovery, molecular simulation, and research efforts across pharmaceutical, biotechnology, and materials research applications. The FDA's procurement of this molecular dynamics modeling platform aligns with the agency's regulatory and research missions, enabling enhanced scientific analysis for drug development and evaluation processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $108.9k | 9/2/25 |